Part 2:

1)"Conclusions
Among adults with multiple myeloma, RVD plus ASCT was associated with longer progression-free survival than RVD alone. No overall survival benefit was observed. (Funded by the National Heart, Lung, and Blood Institute and others; DETERMINATION ClinicalTrials.gov number, NCT01208662.)"

2)"In that trial, in which patients had multiple effective treatment options at relapse and in which many received ASCT after RVD alone, no overall survival benefit of RVD plus ASCT was evident after a median follow-up of more than 7 years."

3)"Safety
The most common treatment-related adverse events that occurred during the entire trial treatment period are summarized in Table S2. Treatment-related events of grade 3 or higher occurred in 279 patients (78.2%) in the RVD-alone group and 344 patients (94.2%) in the transplantation group; 60.5% and 89.9%, respectively, reported treatment-related hematologic adverse events of grade 3 or higher"

4)"However, despite a median follow-up of more than 6 years in our trial, approximately one quarter of the patients had died, and given the lengthy median overall survival among patients in this population in general, we did not observe an overall survival advantage of RVD plus ASCT over RVD alone."

5) "With longer-term use of lenalidomide in the DETERMINATION trial, the 5-year cumulative incidence of second primary hematologic cancers was 1.6% with RVD alone, as compared with 3.5% with RVD plus ASCT"

6) "In the absence of a demonstrated overall survival benefit, however, and in the context of considerations regarding real-world factors such as treatment burden, acute and long-term toxic effects, patient preference, and quality of life, these findings may be taken into account when making treatment decisions."

That is the question and we don't know everyone is different
I h a d mine in 2018 just one small relapse. Went from 10 MG revlimid to 10 then after a bit went back to 5

Sorry Vince, but I haven't had to undergo a SCT. I am in remission for over 15 years now. I was on oral chemo for most of than time with the drug Revlamid. I wish you well with your Stem Cell Transplant. Pedro

So, I've passed the 27month criteria and encouraged to know my chances are not bad.